Crossmark

Do Incretin-Based Therapies Influence the Risk of Cholangiocarcinoma in Type 2 Diabetes Patients? Insights from a Systematic Review and Meta-Analysis

Published Online: 2025-10-11

Published Print: 2025-12

Authors

Yonatan, Eric Ricardo

Jusni, Louis Fabio Jonathan

Alvianto, Steven

Widjanarko, Nicolas Daniel

Usman, Steven Yulius

Muzellina, Virly Nanda
License Information

Text and Data Mining valid from 2025-10-11

Version of Record valid from 2025-10-11
More Information

Article History

Accepted: 5 October 2025

First Online: 11 October 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current